Shingrix 58160-0849
Generic: Zoster Vaccine Recombinant, Adjuvanted
Product NDC
58160-0849- Manufacturer
- Glaxosmithkline Biologicals Sa
- Dosage Form
- Injection, Solution
- Route
- Intramuscular
- Product Type
- Vaccine
- Marketing Start
- July 16, 2025
- Listing Expires
- December 31, 2027
- Application
- BLA125614
Active Ingredients
| Ingredient | Strength |
|---|---|
| Recombinant Varicella Zoster Virus Glycoprotein E Antigen | 50 ug/.5mL |
Packaging Options(1)
10 SYRINGE in 1 CARTON (58160-849-52) / .5 mL in 1 SYRINGE (58160-849-43)